News and Updates

China is rapidly becoming a global leader in medical research. Learn how regulatory reforms and infrastructure growth are shaping its clinical trial sector.

BioVie shares plummet as Phase IIb study for Parkinson’s treatment NE3107 fails to meet primary endpoints in motor function improvement trials.

The rise of betting on clinical trial outcomes sparks ethical concerns among experts. Discover the risks these prediction markets pose to medical research.

Discover how AI is revolutionizing drug development, reducing the $2 billion cost of research, and accelerating the path to life-saving medical breakthroughs.

The FDA has approved Tudriqev for advanced melanoma, offering a new treatment pathway for patients who have developed resistance to anti-PD-1 therapies.

A promising new heart drug targeting inflammation has failed its latest clinical trial, missing key efficacy endpoints for preventing heart attacks.

Clinical trials are falling behind in AI adoption. Discover why industry leaders say underutilization of technology is stalling medical innovation.

The BathMat sensor technology is revolutionizing ICU care by reducing nursing workloads and improving patient monitoring for better clinical outcomes.

New trial data on Dronabinol for PTSD highlights critical gaps in CNS clinical trial design. Learn why trial methodology is failing to capture efficacy.

Tenaya's TN-201 gene therapy shows breakthrough results in reducing heart muscle thickness for HCM patients. Discover the latest clinical trial data.